Picture of GI Innovation logo

358570 GI Innovation Income Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapSucker Stock

Annual income statement for GI Innovation, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue5,6003,5005,31924.35,838
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses36,23271,45258,62348,28446,493
Operating Profit-30,632-67,952-53,305-48,260-40,655
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-150,742-79,833-55,022-59,007-35,135
Provision for Income Taxes
Net Income After Taxes-150,742-79,833-55,495-58,784-35,135
Net Income Before Extraordinary Items
Net Income-150,742-79,833-55,495-58,784-35,135
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-150,742-79,833-55,495-58,784-35,135
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-2,852-1,511-1,071-1,126-605
Dividends per Share